Supha Pharmachem Limited share price
BSE: SUPHA
Key numbers
- Market cap
- ₹ 22.1 Cr
- Current price
- ₹ 0.25
- 52-week high / low
- ₹ 2 / 0
- Stock P/E
- 1.9
- Book value
- ₹ 1.2
- Dividend yield
- 0.00%
- ROCE
- 12.7%
- ROE
- 16.2%
- Debt to equity
- 1.02
- Sales growth (3 yrs)
- -7.1%
- Profit growth (3 yrs)
- 25.4%
- 1-year return
- -83.9%
About Supha Pharmachem Limited
Supha Pharmachem Limited, a pharmaceutical company, trades and sells active pharmaceutical ingredients (API) and intermediates in India and internationally. The company offers API intermediates and other products for the use in iso propyl alcohol, cyclohexane di iso propyl amine, ethyl acetate, hydrazine hydrate, iso propyl alcohol, methylene di chloride, potassium carbonate powder, sodium bi-carbonate, potassium hydroxide flakes, sodium chloride and carbonate, amino isophthalic acid, tellurium(iv) oxide, grignard reagent, iodine, selenium metal powder, and trimethyl sulfoxonium iodide. It also provides tartaric acid salt, thiophenetosylate, couple amine hydrochloride, pantoprazole sulphide, chloro compound, benzimidazole, pantoprazole n-oxide, 4-chloro benzhydryl piperazine, cetirizine base, levo CBP, 2 PMS, indole II, indole III, and R- amide. The company was formerly known as Remedium Lifecare Limited and changed its name to Supha Pharmachem Limited in December 2025. Supha Pharmachem Limited was incorporated in 1988 and is based in Mumbai, India.
Quarterly results
Consolidated figures in ₹ crores
| Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | |
|---|---|---|---|---|
| Sales | 38 | 264 | 113 | 111 |
| Operating profit | -5 | 2 | 2 | 7 |
| Net profit | 1 | -2 | 5 | 9 |
| EPS (₹) | 0.01 | - | 0.05 | 0.10 |
Peers in Drug Manufacturers - Specialty & Generic
Data for information only, not investment advice. Prices end of day.